Legend Biotech (LEGN) Change in Receivables (2020 - 2025)
Legend Biotech (LEGN) posted Change in Receivables of $25.8 million for Q3 2025, up 198.44% on a QoQ basis from -$26.2 million in Q2 2025, and up 108.67% year-over-year from $12.4 million in Q3 2024.
Legend Biotech (LEGN) has 6 years of Change in Receivables data on file, last reported at $25.8 million in Q3 2025.
- In Q3 2025, Change in Receivables rose 108.67% year-over-year to $25.8 million; the TTM figure through Sep 2025 stood at -$72000.0 (down 125.17% YoY), while the FY2024 annual figure was $93.8 million, up 194.72% from the prior year.
- Change in Receivables climbed to $25.8 million in Q3 2025, from -$26.2 million in the prior quarter.
- Across five years, Change in Receivables topped out at $96.7 million in Q1 2024 and bottomed at -$99.0 million in Q4 2023.
- A 5-year average of $4.0 million and a median of $34000.0 in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables plunged 319416.13% — and 2024, when it surged 284411.76%.
- Year by year, Change in Receivables stood at -$48.9 million in 2021, then soared by 99.94% to -$31000.0 in 2022, then plunged by 319416.13% to -$99.0 million in 2023, then soared by 94.36% to -$5.6 million in 2024, then soared by 562.02% to $25.8 million in 2025.
- The last three Change in Receivables figures came in at $25.8 million (Q3 2025), -$26.2 million (Q2 2025), and $5.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 25.79 Mn |
| Sep 30, 2025 | 25.79 Mn |
| Jun 30, 2025 | -26.20 Mn |
| Jun 30, 2025 | -26.20 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Mar 31, 2025 | 5.92 Mn |
| Dec 31, 2024 | -5.58 Mn |
| Dec 31, 2024 | -5.58 Mn |
| Sep 30, 2024 | 12.36 Mn |
| Sep 30, 2024 | 12.36 Mn |
| Jun 30, 2024 | -9.76 Mn |
| Jun 30, 2024 | -9.76 Mn |
| Mar 31, 2024 | 96.73 Mn |
| Mar 31, 2024 | 96.73 Mn |
| Dec 31, 2023 | -99.05 Mn |
| Dec 31, 2023 | -99.05 Mn |
| Sep 30, 2023 | 15.04 Mn |
| Sep 30, 2023 | 15.04 Mn |
| Jun 30, 2023 | -15.01 Mn |
| Jun 30, 2023 | -15.01 Mn |
| Mar 31, 2023 | 34,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | -31,000.00 |
| Dec 31, 2022 | -31,000.00 |
| Sep 30, 2022 | 403,000.00 |
| Sep 30, 2022 | 403,000.00 |
| Jun 30, 2022 | 49.99 Mn |
| Jun 30, 2022 | 49.99 Mn |
| Mar 31, 2022 | -39,000.00 |
| Mar 31, 2022 | -39,000.00 |
| Dec 31, 2021 | -48.91 Mn |
| Dec 31, 2021 | -48.91 Mn |
| Sep 30, 2021 | 13.50 Mn |
| Sep 30, 2021 | 13.50 Mn |
| Jun 30, 2021 | -15.00 Mn |
| Jun 30, 2021 | -15.00 Mn |
| Mar 31, 2021 | 75.00 Mn |
| Mar 31, 2021 | 75.00 Mn |
| Dec 31, 2020 | -45.00 Mn |
| Dec 31, 2020 | -45.00 Mn |